Phase I Trial of BMN 673 and Selected Cytotoxics in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 12 Nov 2019
Price : $35 *
At a glance
- Drugs Talazoparib (Primary) ; Irinotecan; Temozolomide
- Indications Cancer metastases; Solid tumours
- Focus Adverse reactions
- 07 Nov 2019 Status changed from active, no longer recruiting to completed.
- 08 Aug 2019 Planned End Date changed from 30 Jun 2019 to 30 Sep 2020.
- 08 Aug 2019 Planned primary completion date changed from 30 Jun 2019 to 30 Sep 2019.